Product
Standardized Shorter Regimen
1 clinical trial
1 indication
Indication
Multidrug-resistant tuberculosisClinical trial
Refining Multidrug Tuberculosis Treatment With the Ultra Short All Oral RegimenStatus: Active (not recruiting), Estimated PCD: 2023-05-01